How much is Avilar Therapeutics worth in 2026?

Avilar Therapeutics has a current valuation of N/A based on their Seed Round round and secondary market data.

How much funding has Avilar Therapeutics raised?

Avilar Therapeutics has raised N/A in total funding across 1 funding rounds.

Avilar Therapeutics

Drug Discovery

Avilar Therapeutics valuation and funding history | Last updated: February 10, 2023 | 1 funding rounds

Current Valuation

N/A

As of February 10, 2023

Total Funding Raised

N/A

Across 1 round

Last Round

Seed Round

$75.3M

Last Funding

Feb 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 10, 2023	Seed Round	$75.3M	N/A	-

Valuation Analysis

Current Valuation Metrics

Avilar Therapeutics is currently valued at N/A as of February 10, 2023.

Track Avilar Therapeutics Valuation Updates

Get notified when Avilar Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Avilar Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Avilar Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Avilar Therapeutics Worth in 2026?

Avilar Therapeutics is a leading private company in the Drug Discovery sector. Track Avilar Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Avilar Therapeutics Valuation is Determined

Private company valuations like Avilar Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.